EU Rejects Anavex’s Alzheimer’s Drug, But Backs Seven Others

 
• By Eliza Slawther
  
The EMA issued one negative opinion and seven positive opinions for the approval of new drugs in the EU this month (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Europe